Corcept Therapeutics Incorporated (%)
(CORT)| Years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annual |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2004 | 0 | 0 | 0 | 0 | -4.6 | -31.1 | -18.4 | 31.8 | -5.5 | -12.2 | -35.6 | 41.1 | 0 |
| 2005 | -19.4 | -9.1 | -0.9 | 4.4 | -16.9 | 46.2 | 6.8 | -9.8 | -9.9 | -2.6 | -6.6 | -19.8 | -41.6 |
| 2006 | 34.5 | -1.2 | 7.8 | -3.3 | -5.7 | -15.1 | -7.7 | -67.7 | -23.1 | -14 | 10 | 39.8 | -66.3 |
| 2007 | -0.8 | -9.8 | -18.2 | 72.2 | -10.3 | 97.1 | -17.9 | 42.7 | 52.7 | -25.9 | -18.7 | 4.8 | 151.2 |
| 2008 | -14.9 | -2.3 | 25.3 | -13.4 | -16.1 | -16.2 | -5.1 | 0 | -30.7 | 2.3 | -22.7 | 0 | -67 |
| 2009 | -21.6 | 42.5 | 4.4 | -25.2 | -1.1 | -8 | 39.5 | -2.7 | 36.4 | 34.7 | 10.9 | 24.1 | 172.6 |
| 2010 | -7.9 | 9.4 | 1.8 | 18.6 | -4.4 | -3.4 | 4.2 | -14.2 | 39.4 | -8.2 | 9.2 | -1 | 38.9 |
| 2011 | 4.9 | -7.7 | 13.6 | 3.5 | 12.3 | -19.2 | -10.3 | -21 | 9.5 | 2.3 | -0.3 | 8.2 | -11.4 |
| 2012 | 0.3 | 14.6 | 0 | -4.8 | 9.4 | 9.8 | -19.4 | -20.2 | -3.5 | -10.4 | -42.4 | -0.7 | -58.2 |
| 2013 | 51.8 | -24.4 | 22 | -11.5 | 2.8 | -5 | 22 | -21.3 | -4.2 | 6.3 | 27.2 | 49.3 | 124.5 |
| 2014 | 7.2 | -4.7 | 32.9 | 1.4 | -48.9 | 23.9 | -14.6 | 15.5 | -2.9 | 21.3 | -6.8 | -1 | -6.5 |
| 2015 | -3 | 13.8 | 69.2 | 3 | 6.1 | -1.8 | -16.1 | -0.8 | -24.8 | -1.9 | 43.1 | -5.7 | 66 |
| 2016 | -26.7 | 4.7 | 22.5 | 1.9 | 24.7 | -8.2 | 6.2 | -8.1 | 22 | 6.8 | 20.9 | -13.5 | 45.8 |
| 2017 | -2.1 | 26.4 | 21.9 | -13 | 18.6 | 4.3 | 5.7 | 33.7 | 15.8 | 2 | -8.9 | 0.7 | 148.8 |
| 2018 | 27.5 | -34 | 8.3 | 1.4 | 10.9 | -15 | -16.5 | 14.4 | -6.7 | -16.2 | 18.6 | -4.1 | -26 |
| 2019 | -16.3 | 11.5 | -5.9 | 5.3 | -20.6 | 13.3 | 4 | 6.8 | 15.5 | -0.5 | -8.3 | -6.6 | -8.8 |
| 2020 | 3.6 | -0.3 | -5.5 | 6.5 | 19.6 | 11.1 | -11.1 | -15.1 | 37.1 | -3.6 | 34.9 | 15.6 | 114.8 |
| 2021 | 8 | -10.5 | -5.9 | -4.2 | -4.7 | 1.2 | -5.6 | 2.5 | -7.5 | -8.5 | 16.7 | -10 | -23.1 |
| 2022 | -6.7 | -5.9 |